Find clinical trials for Lung Cancer in Kansas City, KS
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Kansas City, KS, USA:
the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...
Phase 1, Phase 2
Westwood, Kansas, United States and 8 other locations
(PK) of BBO-8520, a KRAS G12C (ON) inhibitor, single agent and in combination with pembrolizumab in patients with advanced non-small cell lung...
Phase 1
Kansas City, Kansas, United States and 10 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Kansas City, Missouri, United States and 157 other locations
of Serplulimab + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung...
Phase 3
Fairway, Kansas, United States and 128 other locations
improved patient outcomes compared to pembrolizumab alone in patients with previously treated locally advanced or metastatic non-small cell lung...
Phase 2
Kansas City, Missouri, United States and 32 other locations
IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) tumors that meet protocol-specifie...
Phase 2
Kansas City, Missouri, United States and 33 other locations
comprises adults with either advanced/metastatic non-small cell lung cancer (NSCLC) with non-classical or acquired epidermal growth...
Phase 1, Phase 2
Kansas City, Kansas, United States and 24 other locations
This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...
Phase 3
Kansas City, Missouri, United States and 127 other locations
for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due to muta...
Phase 3
Kansas City, Kansas, United States and 153 other locations
This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non- ...
Phase 2
Kansas City, Kansas, United States and 221 other locations
Clinical trials
Research sites
Resources
Legal